The Duke Clinical Translational Science Institute (Duke CTSI) and North Carolina Translational and Clinical Sciences Institute (NC TraCS) are the academic homes of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) pilot funding programs at Duke University and at UNC Chapel Hill (UNC-CH). The Duke CTSI and NC TraCS are interested in promoting inter-institutional collaborations and pilot funds are now available for eligible new investigative teams.
This pilot program is designed to facilitate novel clinical, population, and translational research that applies or accelerates discovery into testing in clinical or population settings. Projects must demonstrate stakeholder engagement and a high translational potential with a clear path for continued development to move into clinical practice, generate new clinical guidelines, or other applications via subsequent grant support, new company formation, licensing, not-for-profit collaborating, an evidence base that changes practice or other channels. Duke CTSI and UNC-CH are interested in the following types of translational research projects, with an emphasis on interdisciplinary collaborations that test generalizable solutions to translational research problems:
- Generates initial or basic discoveries relevant to human health or disease
- Applies or accelerates discovery into testing in clinical or population settings
- Development and/or evaluation of the evidence base that changes practice
- Investigates how practice improves health policy, health outcomes, and the health of populations
Deadline: Nov. 18, 2019